TIMOTHY M MAYLEBEN
CIK 1242613 · Interim CEO · last filed 2025-02-11
TIMOTHY M MAYLEBEN is an Interim CEO who has filed 75 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider disposed of $11.5K of MRNS on Feb 11, 2025. Across all open-market trades the lifetime net is −$370.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $386.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$386.5K
7
75
-$370.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 2,300 | $0.55 | $1.3K | $0 | 17 | 2025-02-11 |
| Landos Biopharma, Inc. (LABP) Delisted | Interim CEO | — | $22.93 | — | $0 | 5 | 2024-05-23 |
| ESPR | President & CEO | 122,698 | $3.15 | $386.5K | $2.22M | 26 | 2021-01-29 |
| Loxo Oncology, Inc. (LOXO) Delisted | Director | 7,416 | — | — | -$2.83M | 8 | 2019-02-15 |
| Vericel Corp (ASTM) Delisted | President and CEO | 133,000 | — | — | $189.9K | 11 | 2012-08-30 |
| Vericel Corp (ASTMD) Delisted | CEO, President, CFO & Director | 18,068 | — | — | $49.6K | 2 | 2010-03-15 |
| NightHawk Radiology Holdings Inc (NHWK) Delisted | Chief Operating Officer | — | $0.41 | — | $0 | 2 | 2008-02-21 |
Recent Filings
75 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-11 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Disp (D) | −20,857 | -$11.5K | EDGAR |
| 2024-10-15 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Gift (G) | −8,300 | $0 | EDGAR |
| 2024-06-20 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | +2,300 | $0 | EDGAR |
| 2024-05-23 | Landos Biopharma, Inc. (LABP) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-01-19 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | +4,600 | $0 | EDGAR |
| 2023-05-24 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-30 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | +3,600 | $0 | EDGAR |
| 2022-06-22 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-07 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | +2,750 | $0 | EDGAR |
| 2021-12-21 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |